Shanghai, China

Liping Shi

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Hoffmann-La Roche Inc., Shanghai Ruoyu New Materials Co., Ltd. Active years: 2020-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Liping Shi. Retrieved from https://idiyas.com/inventor/liping-shi-xrr7px5z

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 2 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2020-2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Liping Shi in Hepatitis B Treatment

Introduction: Liping Shi is a notable inventor based in Shanghai, China. He has made significant contributions to the field of medicine, particularly in the treatment of hepatitis B virus (HBV) infections. His innovative approach combines different therapeutic agents to enhance treatment efficacy.

Latest Patents: Liping Shi holds a patent for a combination therapy of an HBV capsid assembly inhibitor and an interferon. This invention focuses on compositions and methods for treating hepatitis B virus infection. The combination therapy aims to improve treatment outcomes for patients suffering from this viral infection.

Career Highlights: Liping Shi is associated with Hoffmann-La Roche Inc., a leading global healthcare company. His work at the company has allowed him to contribute to groundbreaking research and development in the pharmaceutical industry.

Collaborations: Some of his notable coworkers include Lu Gao and Isabel Najera, who have collaborated with him on various projects related to hepatitis B treatment.

Conclusion: Liping Shi's innovative work in the field of hepatitis B treatment exemplifies the importance of combining therapies to enhance patient outcomes. His contributions continue to impact the medical community positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…